MicroRNAs (miRNAs) are small non-coding RNAs that act as posttranscriptional regulators of gene expression. In the past few years growing evidence has supported a key role for miRNAs in central nervous system development and homeostasis [1]. More recently,dysregulation in miRNA expres- sion have been observed in different neuropsychiatric disorders,including major depression, and a few studies have suggested a role for miRNAs in the action of mood stabilizers and antidepressants [2]. Based on this, aim of the present study was to evaluate the effects of treatment for 3 and 21 days with agomelatine, a new antidepressant with a unique receptor profile as MT1/MT2 receptors agonist and 5-HT2C receptor antagonist [3], on the miRNome expression profile in rat hippocampus

Early and time-dependent modulation of rat hippocampal miRNome during treatment with agomelatine / D. Tardito, M. Seguini, D. Corrada, I. Merelli, A. Mallei, L. Milanesi, G. Racagni, M. Popoli. - In: EUROPEAN NEUROPSYCHOPHARMACOLOGY. - ISSN 0924-977X. - 23:Suppl. 2(2013 Sep), pp. S312-S312. ((Intervento presentato al 26. convegno ECNP Congress tenutosi a Barcelona nel 2013 [10.1016/S0924-977X(13)70489-9].

Early and time-dependent modulation of rat hippocampal miRNome during treatment with agomelatine

D. Tardito;M. Seguini;A. Mallei;G. Racagni;M. Popoli
2013

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs that act as posttranscriptional regulators of gene expression. In the past few years growing evidence has supported a key role for miRNAs in central nervous system development and homeostasis [1]. More recently,dysregulation in miRNA expres- sion have been observed in different neuropsychiatric disorders,including major depression, and a few studies have suggested a role for miRNAs in the action of mood stabilizers and antidepressants [2]. Based on this, aim of the present study was to evaluate the effects of treatment for 3 and 21 days with agomelatine, a new antidepressant with a unique receptor profile as MT1/MT2 receptors agonist and 5-HT2C receptor antagonist [3], on the miRNome expression profile in rat hippocampus
microRNA ; agomelatine ; antidepressant ; hippocampus
Settore BIO/14 - Farmacologia
set-2013
European College of Neuropsychopharmacology
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/231788
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact